Biotechcancerdrug developmentgene therapyneurologyresearchSTAT Plus – San Diego Biotechnology Network

News Ticker

[ June 5, 2023 ] Staff Research Associate II – UC San Diego Health – San Diego, CA San Diego Biotech Jobs
[ June 5, 2023 ] Supervisor, Laboratory – Bio-techne – San Marcos, CA San Diego Biotech Jobs
[ June 5, 2023 ] UC San Diego Health Recognized for Leadership in Environmental Sustainability News
[ June 5, 2023 ] Cali Biosciences Initiates Second Phase III Study of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use and Presents Consistent and Predictable PK Results Across Multiple Surgeries News
[ June 5, 2023 ] Wounded Warrior Project to Team Up with VA to Empower Veterans at Adaptive Sports Clinic News

No Picture

STAT Plus: Tocagen continues a brain cancer gene therapy clinical trial. Investors fear the worst

May 21, 2019 sandiegobiotech Comments Off

Tocagen pitched the study?s continuation as an encouraging sign for its gene therapy, but its stock price fell sharply. […]

Copyright © 2023 Biotech Networks, LLC